Efficacy and Safety of Lomitapide in Hypercholesterolemia
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Cardiovascular Drugs"
DOI: 10.1007/s40256-017-0214-7
Abstract: BackgroundDespite extensive use of statins, patients with hypercholesterolemia, especially homozygous familial hypercholesterolemia (HoFH), do not achieve recommended targets of low-density lipoprotein cholesterol (LDL-C). There is an urgent need for novel options that could reduce proatherogenic… read more here.
Keywords: hofh; hypercholesterolemia; efficacy safety; cholesterol ... See more keywords
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of preventive cardiology"
DOI: 10.1093/eurjpc/zwab229
Abstract: BACKGROUND Lomitapide is a lipid-lowering agent indicated as adjunct therapy for adult HoFH. OBJECTIVES This study evaluated the medium-term effectiveness and safety of lomitapide in a large cohort of HoFH patients in Europe. METHODS In… read more here.
Keywords: safety; retrospective observational; hofh patients; safety lomitapide ... See more keywords